[Federal Register Volume 85, Number 213 (Tuesday, November 3, 2020)]
[Notices]
[Pages 69633-69634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24255]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning

[[Page 69634]]

individuals associated with the grant applications, the disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Immuno-Oncology Research.
    Date: December 1-2, 2020.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Mehrdad Mohseni, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5211, MSC 7854, Bethesda, MD 20892, 301-435-
0484 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Drug Discovery Involving the Nervous System.
    Date: December 1-2, 2020.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Aurea D. De Sousa, Ph.D., Scientific Review 
Officer, National Institutes of Health, Center for Scientific 
Review, 6701 Rockledge Drive, Room 5186, Bethesda, MD 20892, 301-
827-6829, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Instrumentation, Environmental and 
Occupational Safety.
    Date: December 1-2, 2020.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Rm 6188, MSC 7804, Bethesda, MD 20892, 
(301) 435-1267, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Visual System Biology.
    Date: December 1, 2020.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: John Burch, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, 301-408-
9519, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR: 18-731 Cancer Biology--Workforce Diversity.
    Date: December 1, 2020.
    Time: 12:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Juraj Bies, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Rm. 4158, MSC 7806, Bethesda, MD 20892, 301-435-
1256, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 28, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-24255 Filed 11-2-20; 8:45 am]
BILLING CODE 4140-01-P